
Loading, please wait...

Loading, please wait...

Cognitive rehabilitation in MS remains a cornerstone for managing the cognitive decline often seen in progressive disease stages. However, clinical outcomes often vary significantly between patients. Consequently, a secondary analysis of the landmark CogEx trial investigated which training modules drive the most benefit. The researchers also examined which baseline characteristics predict a positive response to computerized training using the RehaCom platform.
The study found that not all training modules provide the same level of cognitive benefit. Specifically, the Attention/Concentration module showed the strongest correlation with improvements in processing speed. Furthermore, significant gains were also noted in modules focusing on Alertness and Divided Attention. Because processing speed is a primary deficit in progressive MS, focusing on these specific modules may enhance the efficiency of rehabilitation programs.
Identifying potential responders allows clinicians to tailor interventions more effectively. According to the findings, younger age and lower baseline disability, measured by the Expanded Disability Status Scale (EDSS), were significant predictors of success. Interestingly, the baseline cognitive score on the Symbol Digit Modalities Test (SDMT) did not predict whether a patient would improve. Therefore, even patients with lower initial scores might still experience meaningful gains if they are younger and have lower physical disability.
In summary, the specific choice of rehabilitation modules plays a vital role in patient outcomes. Clinicians should prioritize attention-based training to maximize processing speed improvements. Additionally, starting cognitive interventions earlier in the disease course may yield better results before disability levels increase. Consequently, these insights provide a roadmap for more personalized care in progressive MS management.
The Attention/Concentration module showed the strongest link to improvements in information processing speed among participants with progressive MS.
No, the study indicated that baseline SDMT scores do not predict responsiveness. Patients with lower initial scores can still achieve significant improvements.
The research found that younger patients and those with lower EDSS scores (lower physical disability) are more likely to respond positively to cognitive rehabilitation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A secondary analysis of the CogEx study identifies module-specific success and patient predictors for cognitive rehabilitation in progressive MS....
5 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday